Dasatinib Produces Lengthy Remissions of Extramedullary Leukemia: A Retrospective Observational Study
ABSTRACT Since 2004, patients receiving imatinib with relapse in nonâmarrow sites were given dasatinib to preserve control of leukemic marrow. Remissions in CNS and other organs...